Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Urol Oncol. 2013 Aug;31(6):899-903. doi: 10.1016/j.urolonc.2011.06.014. Epub 2011 Aug 6.
To retrospectively assess the significance of gender as a predictor of intravesical recurrence following nephroureterectomy for urothelial carcinoma of the upper urinary tract (UC-UUT).
This study included 502 consecutive patients (360 male and 142 female) who were diagnosed as having clinically localized UC-UUT and underwent nephroureterectomy. Clinicopathologic outcomes of these patients were analyzed focusing on the impact of gender.
The incidence of intravesical recurrence in male patients (41.9%) was significantly greater than that in female patients (27.5%). Despite the lack of significant differences in cancer-specific and overall survivals with respect to gender, the intravesical recurrence-free survival in male patients was significantly worse than that in female patients. Of several parameters examined, univariate analysis identified gender, tumor site, and tumor focality as significant predictors of intravesical recurrence following nephroureterectomy. Of these, only gender and tumor site appeared to be independently associated with intravesical recurrence-free survival on multivariate analysis. Furthermore, there was a significant difference in intravesical recurrence-free survival according to positive numbers of these two independent factors; that is, intravesical recurrence occurred in 12 of 55 patients who were negative for both risk factors (21.8%), 96 of 280 positive for a single risk factor (34.3%), and 82 of 167 positive for both risk factors (49.1%).
The incidence of intravesical recurrence following nephroureterectomy for UC-UUT is comparatively high. Therefore, it would be potentially important to perform careful follow-up targeting intravesical recurrence for such patients, particularly for male patients and/or patients with tumor located at the ureter.
回顾性评估性别作为预测上尿路上皮癌(UC-UUT)患者行肾输尿管切除术后膀胱内复发的指标的意义。
本研究纳入了 502 例临床局限性 UC-UUT 患者(360 例男性和 142 例女性),这些患者均接受了肾输尿管切除术。分析这些患者的临床病理结果,重点关注性别对这些结果的影响。
男性患者(41.9%)的膀胱内复发发生率明显高于女性患者(27.5%)。尽管性别对癌症特异性和总体生存率没有显著影响,但男性患者的膀胱内无复发生存率明显差于女性患者。在检查的几个参数中,单因素分析确定了性别、肿瘤部位和肿瘤局灶性是肾输尿管切除术后膀胱内复发的显著预测因素。其中,仅性别和肿瘤部位在多因素分析中与膀胱内无复发生存率独立相关。此外,根据这两个独立因素的阳性数量,膀胱内无复发生存率存在显著差异;即,在这两个危险因素均为阴性的 55 例患者中有 12 例(21.8%)发生膀胱内复发,在仅单一危险因素阳性的 280 例患者中有 96 例(34.3%)发生膀胱内复发,在两个危险因素均为阳性的 167 例患者中有 82 例(49.1%)发生膀胱内复发。
UC-UUT 患者行肾输尿管切除术后膀胱内复发的发生率相对较高。因此,对这些患者,尤其是男性患者和/或肿瘤位于输尿管的患者,进行膀胱内复发的密切随访可能非常重要。